MAZE THERAPEUTICS, INC. (MAZE)

SEC filing

MAZE THERAPEUTICS, INC.

MAZE · CIK 1842295

4 · Jan 9, 2026 · Bernstein Harold sold 25.16K shares at $40.20/share ($1.0M); exercised options for 25.16K shares

Bernstein Harold sold 25.16K shares at $40.20/share ($1.0M); exercised options for 25.16K shares

xslF345X05/form4-01092026_090123.xml

xslF345X05/form4-01092026_090123.xmlSEC.gov

Graphics and non-inline formats (not embedded below).